Insulet Corporation last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $842.0 million (+19.2% year over year) and diluted EPS of $2.03. It usually reports 35–49 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 17, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 18, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 35–49 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
842
+19.2%
|
141
+61.1%
|
2.03
+63.7%
|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
802
+23.5%
|
95
+322.2%
|
1.37
+328.1%
|
|
May 6, 2026
36 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
762
+33.9%
|
91
+157.3%
|
1.30
+160.0%
|
|
Feb 18, 2026
49 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
784
+31.2%
|
102
+0.9%
|
1.44
+5.7%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
706
+29.9%
|
88
+13.0%
|
1.24
+14.8%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
649
+32.9%
|
22
-88.1%
|
0.32
-87.6%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
569
+28.8%
|
35
-31.3%
|
0.50
-31.5%
|
|
Feb 20, 2025
51 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
598
+17.2%
|
101
-2.5%
|
1.36
+10.6%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PODD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1145197
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.